Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a late-stage clinical biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral ...
European regulators have recommended expanding Maviret, a dual direct-acting antiviral, to include acute hepatitis C infection in adults and children.
Hepatitis C and opioid use disorder are both chronic but treatable conditions. Yet many Americans living with this deadly combination aren’t offered treatment. Imagine going to your doctor with strep ...
As the opioid epidemic has worsened in the United States, prevalence of hepatitis C has also increased. Hepatitis C is a bloodborne virus that damages the liver. It is mainly spread through sharing ...
AbbVie (NYSE: ABBV) today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending the approval of MAVIRET® ...
Figure 1. The direct-acting antiviral targets in the hepatitis C virus replication cycle. NS3/4A protease inhibitors target the NS3/4A protease enzyme which is needed for the virus to develop the ...
A person is sitting at a table and looking at pill bottles. Medicare Part D or MAPD plans should cover hepatitis C medications, but the exact covered drugs depend on the plan. Infused drugs and other ...
Hepatitis C is the leading cause of chronic liver disease and liver cancer in the world and affects an estimated 51 million people globally. Though the viral infection is easily diagnosable and ...
MANCHESTER and LONDON, England — Alison Starkie spends her days tracking down people who need testing or treatment for ...
A person can have hepatitis C with no symptoms. Liver enzyme tests can help detect and diagnose a hepatitis C infection by showing liver damage and inflammation. Hepatitis C is a contagious liver ...
Fewer people have gotten crucial medication for hepatitis C under Medi-Cal in recent years, troubling advocates who have pushed to expand the lifesaving treatment. Hepatitis C, a slow-moving virus ...
Additional Data Presented Demonstrate High In Vitro Antiviral Potency and In Vivo Efficacy for AT-587, Atea’s Potential First ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results